Clinical trial
Induction Chemotherapy With Carboplatin and Navelbine Oral(R) Followed by Concomitant Navelbine Oral(R) and Irradiation in Local-regionally Advanced Non-small Cell Lung Cancer. A Randomized Phase II Study.
NCT00887783 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induction Chemotherapy With Carboplatin and Navelbine Oral(R) Followed by Concomitant Navelbine Oral(R) and Irradiation in Local-regionally Advanced Non-small Cell Lung Cancer. A Randomized Phase II Study.
- Lead sponsor
- Odense University Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 1, 2009
- Completion date
- September 1, 2016
- Enrollment
- 117 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer